Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shir Elimeleh

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|April 13, 2026
Response to SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future DirectionsRanel Loutati, Viana Copeland, Shir Elimeleh, et al.
JACC. Heart Failure|March 18, 2026
Frailty Redefines Risk Across the Weight Spectrum in Heart FailureViana Copeland, Boris Fishman, Shir Elimeleh, et al.
Journal of Clinical Medicine|March 28, 2026
Uric Acid Variability Is Associated with Poor Prognosis in Heart FailureViana Copeland, Shir Elimeleh, Assi Milwidsky, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 30, 2026
Heart Failure and Tricuspid Regurgitation: The Role of SGLT2 Inhibitors in Improving OutcomesRanel Loutati, Viana Copeland, Shir Elimeleh, et al.
JACC. Advances|October 30, 2025
Improved Survival in Octogenarians With Heart Failure: 15-Year Cohort Study From a National Referral CenterViana Copeland, Boris Fishman, Assi Milwidsky, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Heart Journal. Cardiovascular Pharmacotherapy|April 13, 2026
Response to SGLT2 Inhibitors in Heart Failure With Tricuspid Regurgitation: Clinical Interpretation and Future DirectionsRanel Loutati, Viana Copeland, Shir Elimeleh, et al.
JACC. Heart Failure|March 18, 2026
Frailty Redefines Risk Across the Weight Spectrum in Heart FailureViana Copeland, Boris Fishman, Shir Elimeleh, et al.
Journal of Clinical Medicine|March 28, 2026
Uric Acid Variability Is Associated with Poor Prognosis in Heart FailureViana Copeland, Shir Elimeleh, Assi Milwidsky, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 30, 2026
Heart Failure and Tricuspid Regurgitation: The Role of SGLT2 Inhibitors in Improving OutcomesRanel Loutati, Viana Copeland, Shir Elimeleh, et al.
JACC. Advances|October 30, 2025
Improved Survival in Octogenarians With Heart Failure: 15-Year Cohort Study From a National Referral CenterViana Copeland, Boris Fishman, Assi Milwidsky, et al.
Pageof 1